SCHEMBL7106631

SCHEMBL7106631

O=S(=O)([N]CCc1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.49
ALDH1A1 P00352 4/20 0.44
HTR6 P50406 3/20 0.43
TRPA1 O75762 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2A6 P11509 1/20 0.42
MIF P14174 1/20 0.42
HIF1A Q16665 1/20 0.42
CYP2A13 Q16696 1/20 0.42
EPAS1 Q99814 1/20 0.42
CA2 P00918 6/20 0.41
CA1 P00915 4/20 0.41
CA9 Q16790 3/20 0.41
CA12 O43570 2/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
KEAP1 Q14145 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5700550 0.79 NPC1 (0.45) ALDH1A1HTR6TRPA1MIFCA2
SCHEMBL9283543 0.78 PSIP1 (0.50) GAAALDH1A1HTR6CA2CA1
SCHEMBL4520701 0.78 POLB (0.47) GAAALDH1A1TRPA1CYP2E1CYP2A6
SCHEMBL3234699 0.74 TDP1 (0.49) ALDH1A1HTR6TSHRKMT2AKDM4E
SCHEMBL6753703 0.73 KDM4E (0.42) ALDH1A1HTR6MEN1KMT2AKDM4E
SCHEMBL8792482 0.73 TDP1 (0.47) ALDH1A1MEN1TSHRKMT2AKEAP1
SCHEMBL5700129 0.72 PSIP1 (0.54) ALDH1A1HTR6CA2CA1CA9
SCHEMBL8394582 0.72 GBA1 (0.46) ALDH1A1HTR6KMT2AKEAP1CYP2C9
SCHEMBL163261 0.72 TDP1 (0.46) ALDH1A1TSHRKEAP1KDM4ELMNA
SCHEMBL8395499 0.69 HDAC3 (0.47) GAAALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216451-A1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2003-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216451-A1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade TFPI, PLAT, F2 GAA 2007/4885ALDH1A1 3342/4885HTR6 2203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.